The trademark application REXXULTY was filed by Otsuka Pharmaceutical Co., Ltd., a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on July 20, 2015, and it was registered by office on October 27, 2015 without any oppositions.
The application was filed in Danish (English was selected as the second language).
The renewal of the trademark was recorded by the office on December 1, 2024.
A transfer of the trademark registration was recorded on August 31, 2015. Change of name and professional address of the trademark registration was recorded on July 21, 2020. Appointment and Replacement of representative of the trademark registration was recorded on December 16, 2020.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical and veterinary preparations
Sanitary preparations for medical purposes
Vaccines
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases of, caused by or acting on the central nervous system
Pharmaceutical preparations and substances that act on the central nervous system
Stimulants for the central nervous system
Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases
Pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, stroke, depression, mood swings, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease, insomnia, Parkinson's disease, schizophrenia, bipolar disorder, ADHD, oncology, pain, alcoholism and addiction
Preparations, substances, reagents and compositions for diagnostic and medical purposes.